Literature DB >> 17625983

Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension.

Geoffrey C Nguyen1, Dorry L Segev, Paul J Thuluvath.   

Abstract

BACKGROUND & AIMS: Advanced liver disease and complications of portal hypertension are common indications for hospitalization. Our objectives were to characterize longitudinal trends in incidence, characteristics, and outcomes of patients hospitalized with complications of portal hypertension using a nationally representative data set.
METHODS: Admissions for complications of portal hypertension (hepatic encephalopathy, ascites, or variceal bleed) were identified from the Nationwide Inpatient Sample between 1998 and 2003 using International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes. International Classification of Diseases, 9th Revision, Clinical Modification procedural codes were used to identify liver transplantation and portosystemic shunt procedures. National estimates for incidence of hospitalization over time, in-hospital mortality, and hospital charges accounted for survey design.
RESULTS: Hospitalization rates increased significantly by 5% annually between 1998 and 2003, particularly in the Northeast and the South. The prevalence of hepatitis C-related advanced liver disease among these hospitalized patients increased from 12.9% to 23.7%, and in those with HCV and concurrent alcohol-related disease the rate increased from 5.6% to 11.2%. US population-based in-hospital mortality increased modestly from 1.9 to 2.1 per 100,000 (P<.001), with hepatorenal syndrome as the strongest predictor of death (odds ratio, 9.5; 95% confidence interval, 8.4-10.7). The inflation-adjusted total economic burden of decompensated cirrhosis increased from $1.15 billion to $2.1 billion during the 6-year period (P<.003).
CONCLUSIONS: A significant increase in the incidence of hospitalization for complicated portal hypertension between 1998 and 2003 and a growing burden of hepatitis C-related disease have profound economic impact and underscore the need for interventions to prevent progression to advanced liver disease.

Entities:  

Mesh:

Year:  2007        PMID: 17625983     DOI: 10.1016/j.cgh.2007.04.027

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  26 in total

1.  Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis.

Authors:  Muhammad Ali; Ashwin N Ananthakrishnan; Emily L McGinley; Kia Saeian
Journal:  Dig Dis Sci       Date:  2011-01-30       Impact factor: 3.199

2.  Hospital readmissions among patients with decompensated cirrhosis.

Authors:  Michael L Volk; Rachel S Tocco; Jessica Bazick; Mina O Rakoski; Anna S Lok
Journal:  Am J Gastroenterol       Date:  2011-09-20       Impact factor: 10.864

3.  Hospitalization for complications of cirrhosis: does volume matter?

Authors:  Anand Singla; James L Hart; Youfu Li; Jennifer F Tseng; Shimul A Shah
Journal:  J Gastrointest Surg       Date:  2010-11-25       Impact factor: 3.452

Review 4.  Multidisciplinary management of patients with cirrhosis: a need for care coordination.

Authors:  Jessica L Mellinger; Michael L Volk
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-06       Impact factor: 11.382

5.  Insurance Payer Type and Patient Income Are Associated with Outcomes after Total Shoulder Arthroplasty.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  J Rheumatol       Date:  2019-06-01       Impact factor: 4.666

6.  Variation among United States hospitals in inpatient mortality for cirrhosis.

Authors:  Jessica L Mellinger; Caroline R Richardson; Amit K Mathur; Michael L Volk
Journal:  Clin Gastroenterol Hepatol       Date:  2014-09-28       Impact factor: 11.382

7.  Systemic sclerosis is associated with knee arthroplasty outcomes: a National US study.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  Clin Rheumatol       Date:  2019-08-23       Impact factor: 2.980

Review 8.  Palliative care for patients with end-stage liver disease.

Authors:  Anne M Larson
Journal:  Curr Gastroenterol Rep       Date:  2015-05

9.  The Effect of Hospital Characteristics on Racial/Ethnic Variation in Cirrhosis Mortality.

Authors:  Apurba Chakrabarti; Nicholas H Osborne; Amol S Rangnekar; Amit K Mathur
Journal:  J Racial Ethn Health Disparities       Date:  2016-04-11

10.  Factors that predict short-term intensive care unit mortality in patients with cirrhosis.

Authors:  Ranjeeta Bahirwani; Marwan Ghabril; Kimberly A Forde; Hemant Chatrath; Karen M Wolf; Lindsay Uribe; K Rajender Reddy; Barry Fuchs; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-16       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.